|
Volumn 151, Issue 5, 2017, Pages 1173-1174
|
Comprehensive and Individualized Patient Care in Idiopathic Pulmonary Fibrosis: Refining Approaches to Diagnosis, Prognosis, and Treatment
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTACID AGENT;
ENZYME INHIBITOR;
INDOLE DERIVATIVE;
NINTEDANIB;
NONSTEROID ANTIINFLAMMATORY AGENT;
PIRFENIDONE;
PYRIDONE DERIVATIVE;
BIOPSY;
EARLY DIAGNOSIS;
EARLY INTERVENTION;
HEALTH BEHAVIOR;
HUMAN;
IDIOPATHIC PULMONARY FIBROSIS;
LUNG;
PATHOLOGY;
PATIENT CARE;
PERSONALIZED MEDICINE;
PROGNOSIS;
X-RAY COMPUTED TOMOGRAPHY;
ANTACIDS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
BIOPSY;
EARLY DIAGNOSIS;
EARLY MEDICAL INTERVENTION;
ENZYME INHIBITORS;
HEALTH BEHAVIOR;
HUMANS;
IDIOPATHIC PULMONARY FIBROSIS;
INDOLES;
LUNG;
PATIENT-CENTERED CARE;
PRECISION MEDICINE;
PROGNOSIS;
PYRIDONES;
TOMOGRAPHY, X-RAY COMPUTED;
|
EID: 85019149569
PISSN: 00123692
EISSN: 19313543
Source Type: Journal
DOI: 10.1016/j.chest.2017.03.017 Document Type: Note |
Times cited : (10)
|
References (0)
|